We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Investors Fight Bid To Nix Price-Fixing Suit

Law360, Washington (January 11, 2018, 9:21 PM EST) -- Two pension plans on Wednesday hit back against a request by Teva Pharmaceutical Industries Ltd. and several of its former officers to throw out their proposed investor class action over Teva’s alleged price-fixing in the generic-drug market, defending the quality of their pleadings to a Connecticut federal court.

Teva and the executives asked the court to dismiss the case through a number of filings in December on the grounds that the investors’ lawsuit — which claims various securities violations over the alleged price-fixing scheme — made up...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.